Similar articles

• The biochemical basis of gangliosidoses.

  Sandhoff K, Conzelmann E. Sandhoff K, et al. Neuropediatrics. 1984 Sep;15 Suppl:85-92. doi: 10.1055/s-2008-1052387. Neuropediatrics. 1984. PMID: 6242704 No abstract available.
• Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.

  Huang JQ, Trasler JM, Igdoura S, Michaud J, Hanal N, Gravel RA. Huang JQ, et al. Hum Mol Genet. 1997 Oct;6(11):1879-85. doi: 10.1093/hmg/6.11.1879. Hum Mol Genet. 1997. PMID: 9302266
• Morphology of the gangliosidoses.

  Goebel HH. Goebel HH. Neuropediatrics. 1984 Sep;15 Suppl:97-106. doi: 10.1055/s-2008-1052389. Neuropediatrics. 1984. PMID: 6100800
• Lysosomal storage diseases.

  Glew RH, Basu A, Prence EM, Remaley AT. Glew RH, et al. Lab Invest. 1985 Sep;53(3):250-69. Lab Invest. 1985. PMID: 2993742 Review. No abstract available.
• The clinical aspects of adult hexosaminidase deficiencies.

  Federico A, Palmeri S, Malandrini A, Fabrizi G, Mondelli M, Guazzi GC. Federico A, et al. Dev Neurosci. 1991;13(4-5):280-7. doi: 10.1159/000112174. Dev Neurosci. 1991. PMID: 1840098 Review.